Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20,486 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
Liu X, Wu M, Peng Y, Chen X, Sun J, Huang F, Fan Z, Zhou H, Wu X, Yu G, Zhang X, Li Y, Xiao Y, Song C, Xiang AP, Liu Q. Liu X, et al. Among authors: xiao y. Cell Transplant. 2014;23(9):1087-98. doi: 10.3727/096368912X661319. Cell Transplant. 2014. PMID: 23294601 Free article. Clinical Trial.
Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H. Liu QF, et al. Among authors: xiao y. Biol Blood Marrow Transplant. 2009 Nov;15(11):1376-85. doi: 10.1016/j.bbmt.2009.06.017. Epub 2009 Aug 19. Biol Blood Marrow Transplant. 2009. PMID: 19822296 Free article. Clinical Trial.
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study.
Liu H, Zhai X, Song Z, Sun J, Xiao Y, Nie D, Zhang Y, Huang F, Zhou H, Fan Z, Tu S, Li Y, Guo X, Yu G, Liu Q. Liu H, et al. Among authors: xiao y. J Hematol Oncol. 2013 Feb 8;6:15. doi: 10.1186/1756-8722-6-15. J Hematol Oncol. 2013. PMID: 23394705 Free PMC article. Clinical Trial.
Mesenchymal stem cells versus mesenchymal stem cells combined with cord blood for engraftment failure after autologous hematopoietic stem cell transplantation: a pilot prospective, open-label, randomized trial.
Xiong YY, Fan Q, Huang F, Zhang Y, Wang Y, Chen XY, Fan ZP, Zhou HS, Xiao Y, Xu XJ, Dai M, Xu N, Sun J, Xiang P, Huang XJ, Liu QF. Xiong YY, et al. Among authors: xiao y. Biol Blood Marrow Transplant. 2014 Feb;20(2):236-42. doi: 10.1016/j.bbmt.2013.11.002. Epub 2013 Nov 8. Biol Blood Marrow Transplant. 2014. PMID: 24216182 Free article. Clinical Trial.
Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China.
Li Y, Xu W, Jiang Z, Gao Y, Pang Y, Li L, OuYang L, Zhang L, Liu Z, Wang Y, Xiao Y, Huang X. Li Y, et al. Among authors: xiao y. Tumour Biol. 2014 Jun;35(6):5869-76. doi: 10.1007/s13277-014-1777-4. Epub 2014 Mar 25. Tumour Biol. 2014. Retraction in: Tumour Biol. 2014 Nov;35(11):11693. doi: 10.1007/s13277-014-2603-8 PMID: 24664582 Retracted.
20,486 results
You have reached the last available page of results. Please see the User Guide for more information.